Illuminating the route of precision medicine and inhibitor discovery: real-time measurement of DNA repair capacity with molecular beacons
Illuminating the route of precision medicine and inhibitor discovery: real-time measurement of DNA repair capacity with molecular beacons |
|
https://doi.org/10.18632/oncotarget.26056
Alfonso Bellacosa,
and Timothy Yen
|
| 36818-36819 |
New developments of metformin in the clinical cancer area
New developments of metformin in the clinical cancer area |
|
https://doi.org/10.18632/oncotarget.26418
Lev M. Berstein
|
| 36820-36821 |
Unraveling the genomic determinants of response to CDK4/6 inhibitors
Unraveling the genomic determinants of response to CDK4/6 inhibitors |
|
https://doi.org/10.18632/oncotarget.26109
Lacey M. Litchfield,
Yue W. Webster,
and Sean G. Buchanan
|
| 36822-36823 |
How I treat rituximab refractory patients with WM
How I treat rituximab refractory patients with WM |
|
https://doi.org/10.18632/oncotarget.26411
Maria Gavriatopoulou,
Ioannis Ntanasis-Stathopoulos,
Efstathios Kastritis,
and Meletios Athanasios Dimopoulos
|
| 36824-36825 |
Time to go functional! Determining tumors’ DNA repair capacity ex vivo
Time to go functional! Determining tumors’ DNA repair capacity ex vivo |
|
https://doi.org/10.18632/oncotarget.26419
Manuela Tumiati,
Sakari Hietanen,
and Liisa Kauppi
|
| 36826-36827 |
Role of ASXL1 mutation in impaired hematopoiesis and cellular senescence
Role of ASXL1 mutation in impaired hematopoiesis and cellular senescence |
|
https://doi.org/10.18632/oncotarget.26423
Masahiro Uni,
and Mineo Kurokawa
|
| 36828-36829 |
Heparanase inhibitors restrain mesothelioma
Heparanase inhibitors restrain mesothelioma |
|
https://doi.org/10.18632/oncotarget.26243
Moshe Lapidot,
Uri Barash,
Israel Vlodavsky,
and Harvey Pass
|
| 36830-36832 |
Novel screen for anti-cancer drugs that elevate chromosome instability (CIN) using human artificial chromosome (HAC)
Novel screen for anti-cancer drugs that elevate chromosome instability (CIN) using human artificial chromosome (HAC) |
|
https://doi.org/10.18632/oncotarget.26406
Natalay Kouprina,
Yves Pommier,
and Vladimir Larionov
|
| 36833-36835 |
Integrated landscape of copy number variation and RNA expression associated with nodal metastasis in invasive ductal breast carcinoma
Integrated landscape of copy number variation and RNA expression associated with nodal metastasis in invasive ductal breast carcinoma |
|
https://doi.org/10.18632/oncotarget.26386
Michael Behring,
Sadeep Shrestha,
Upender Manne,
Xiangqin Cui,
Agustin Gonzalez-Reymundez,
Alexander Grueneberg,
and Ana I. Vazquez
|
| 36836-36848 |
Thioredoxin interacting protein promotes invasion in hepatocellular carcinoma
Thioredoxin interacting protein promotes invasion in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.26402
Aysim Gunes,
Ezgi Bagirsakci,
Evin Iscan,
Gulcin Cakan-Akdogan,
Umut Aykutlu,
Serif Senturk,
Gunes Ozhan,
Esra Erdal,
Deniz Nart,
Funda Yilmaz Barbet,
and Nese Atabey
|
| 36849-36866 |
Eradication of LIG4-deficient glioblastoma cells by the combination of PARP inhibitor and alkylating agent
Eradication of LIG4-deficient glioblastoma cells by the combination of PARP inhibitor and alkylating agent |
|
https://doi.org/10.18632/oncotarget.26409
Monika Toma,
Monika Witusik-Perkowska,
Marzena Szwed,
Robert Stawski,
Janusz Szemraj,
Malgorzata Drzewiecka,
Margaret Nieborowska-Skorska,
Maciej Radek,
Pawel Kolasa,
Ksenia Matlawska-Wasowska,
Tomasz Sliwinski,
and Tomasz Skorski
|
| 36867-36877 |
Analysis of mutations in primary and metastatic synovial sarcoma
Analysis of mutations in primary and metastatic synovial sarcoma |
|
https://doi.org/10.18632/oncotarget.26416
Zhuo Xing,
Lei Wei,
Xiaoling Jiang,
Jeffrey Conroy,
Sean Glenn,
Wiam Bshara,
Tao Yu,
Annie Pao,
Shinya Tanaka,
Akira Kawai,
Christopher Choi,
Jianmin Wang,
Song Liu,
Carl Morrison,
and Y. Eugene Yu
|
| 36878-36888 |
